Adult stem cell therapy for COVID-19 sequelae begins in Japan for first time in the world
LOS ANGELES: Japan’s Kyushu Certified Special Committee for Regenerative Medicine, Appropriate Opinion on Treatment Plan for COVID-19 Sequelae Using Autologous Adipose-derived Mesenchymal Stem Cells The patented technology developed by Korea’s Biostar Stem Cell Research Institute is scheduled to start in late December at the Japanese medical corporation Yesunghoe Trinity Clinic Fukuoka Stem cell therapy developed […]
![[Novel] The Road to Shamawes ⑯](http://www.theasian.asia/wp-content/themes/city-desk/timthumb.php?src=http%3A%2F%2Fwww.theasian.asia%2Fwp-content%2Fuploads%2F2013%2F08%2FAshraf-2novel-news_9601.jpg&q=90&w=300&h=0&zc=1 "[Novel] The Road to Shamawes ⑯")
